Article
Implementation of a simplified flow cytometric assays for minimal residual disease monitoring in childhood acute lymphoblastic leukemia
Registro en:
VINHAS, E.; LUCENA-SILVA, N.; PEDROSA, F. Implementation of a Simplified Flow Cytometric Assays for Minimal Residual Disease Monitoring in Childhood Acute Lymphoblastic Leukemia. Cytometry. Part B, Clinical Cytometry, v. 94, n. 1, p. 94–99, 2018.
1552-4957
10.1002/cyto.b.21394
Autor
Vinhas, Ester
Lucena-Silva, Norma
Pedrosa, Francisco
Resumen
Monitoring minimal residual disease (MRD) in B-lineage acute lymphoblastic leukemia (ALL) to assess treatment response is crucial for risk assignment. Flow cytometry can be used to monitor MRD in ALL but the implementation of this approach requires extensive expertise. If resources are limited, the costs of full flow cytometric MRD testing might be prohibitive. 2050-01-01